PRESTRELSKI STEVEN (Chief Scientific Officer) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
Common Stock
Shares
+384.78K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+110K
Price / share
—
Trade value
—
% of position
Net shares
+494.78K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/5/2021 | A · Award | +384.78K | — | — | New position | 0.00 | 384.78K |
| Common Stock Direct | 10/5/2021 | A · Award | +110K | — | — | 28.6% | 384.78K | 494.78K |
| Total | +494.78K | $0.00 | ||||||
Stock Option (Right to Buy)
Common Stock
11.23K shares
Shares
+11.23K
Strike price
0.69
Held after
11.23K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
28.07K shares
Shares
+28.07K
Strike price
1.55
Held after
28.07K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
11.27K shares
Shares
+11.27K
Strike price
1.55
Held after
11.27K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
14.04K shares
Shares
+14.04K
Strike price
5.93
Held after
14.04K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
25K shares
Shares
+25K
Strike price
13.88
Held after
25K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
25K shares
Shares
+25K
Strike price
3.94
Held after
25K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock11.23K shares | 10/5/2021 | A · Award | +11.23K | 0.69 | — | 11.23K |
| Stock Option (Right to Buy) Direct | Common Stock28.07K shares | 10/5/2021 | A · Award | +28.07K | 1.55 | — | 28.07K |
| Stock Option (Right to Buy) Direct | Common Stock11.27K shares | 10/5/2021 | A · Award | +11.27K | 1.55 | — | 11.27K |
| Stock Option (Right to Buy) Direct | Common Stock14.04K shares | 10/5/2021 | A · Award | +14.04K | 5.93 | — | 14.04K |
| Stock Option (Right to Buy) Direct | Common Stock25K shares | 10/5/2021 | A · Award | +25K | 13.88 | — | 25K |
| Stock Option (Right to Buy) Direct | Common Stock25K shares | 10/5/2021 | A · Award | +25K | 3.94 | — | 25K |